The economics of follow-on drug research and development Joseph A. DiMasiCherie Paquette Original Research Article 23 September 2012 Pages: 1 - 14
Are the economics of pharmaceutical research and development changing? Henry Grabowski Review Article 23 September 2012 Pages: 15 - 24
The effects of pharmaceutical consumption and obesity on the quality of life in the Organization of Economic Cooperation and Development (OECD) countries H. E. Frech IIIRichard D. Miller Jr Original Research Article 23 September 2012 Pages: 25 - 36
Changes in the costs of treating mental health disorders Ernst R. Berndt Review Article 23 September 2012 Pages: 37 - 50
Impediments to the diffusion of innovative medicines in Europe Oliver Schöffski Review Article 23 September 2012 Pages: 51 - 64
The impact of healthcare reform in The Netherlands Frans Rutten Review Article 23 September 2012 Pages: 65 - 71
Global principles for better healthcare Edward Bramley-Harker Review Article 23 September 2012 Pages: 73 - 79
The role of pharmacoepidemiology and pharmacoeconomics in promoting access and stimulating innovation Jerry Avorn Review Article 23 September 2012 Pages: 81 - 86
The policy implications of gender mainstreaming for healthcare research in the EU Ineke KlingePeggy Maguire Review Article 23 September 2012 Pages: 87 - 93